SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Allinder who wrote (54780)7/16/2000 9:16:45 AM
From: StocksDATsoar   of 150070
 
netcognizance.com

Steve Newby of genomicsfund.com

Author Mike Carrozzo
Report Source Steve Newby
(Added 7/12/2000 12:55:51 PM)Categories: Stock Picks

Email link to this Article

Steve Newby of genomicsfund.com- CRA, HGSI, GLGC, VGIN, MLNM

His fund owns 21 top tier genome stocks, with no biotech stocks. It requires a minimum initial investment of $5,000.

The fund diversifies among genome sectors including bioinformatics and pharmagenomics.

It was the best performing mutual fund in 2Q, up 39% compared to a decline of 2.66% by the S&P 500 and 13.26% by the NASDAQ.

They have $16 million in assets

Looking for the long-term he feels that this is a very exciting area that has just begun. He feels that we are at the beginning of a great cycle in genome.

He expects no high turnover and looks at companies with only strong fundamentals and good long-term growth.

He admits that he knows very little about genomes.

The fund is set at 25-28 top companies and he expects it to stay around that number.

CRA, HGSI, GLGC, VGIN, and MLNM are among his top holdings.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext